Wayfinder Biosciences Email Format

Biotechnology ResearchWashington, United States11-50 Employees

Wayfinder Biosciences is a biotechnology company based in Seattle that develops orally administered small molecules designed to modulate RNAs that encode disease-relevant targets. Its proprietary platform integrates screening with computational techniques to quickly identify RNA-targeting compounds that are potent, selective, and biologically active. The company's programs aim at targets in oncology and neurodegenerative diseases that have traditionally been difficult to reach. Wayfinder was founded by RNA scientists from the University of Washington.

Its potential customers and collaborators include pharmaceutical and research partners pursuing RNA-targeting therapies for cancer and neurodegenerative conditions. In April 2025, Wayfinder announced a collaboration with Daiichi Sankyo centered on a neurodegeneration target.

Sign up for free to view info

Company overview Employee directory